The Plenary Session at the ATS 2023 International Conference raised the topic of misinformation in health care — with a few laughs along the way — from Keynote Speaker Timothy Caulfield, along with the installation of ATS President M. Patricia Rivera, MD, ATSF.

M. Patricia Rivera, MD, ATSF, the new president of the ATS for 2023-2024, shares inspirational influences in her life, her journey through the ATS, and the Society’s strategic framework for the coming year.

Panelists Joseph V. Sakran, MD, MPH, MPA; Emmy Betz, MD, MPH; and Fatimah L. Dreier, MSc, MBA, discussed their personal experiences with gun violence and how they were inspired to advocate for reform within the communities they serve.

Sreyankar Nandy, MD, won the ATS 2023 Building Education to Advance Research (BEAR) Cage competition with his endobronchial optical coherence tomography concept for the early microscopic diagnosis and monitoring of interstitial lung disease. The three finalists were Marco Almeda, MD; Dr. Nandy; and Ananth Charya, MD, MS.

Hundreds of students and early career professionals got a head start on their ATS 2023 International Conference experience by taking part in specialty programming designed to elevate the next generation of respiratory clinicians and researchers.

Over 100 scientific sessions from the ATS 2023 International Conference will be available for on-demand viewing. These sessions cover areas of pulmonary, critical care, and sleep medicine and will be accessible for viewing for one year to all who attended in person, as well as anyone who signs up for access through the ATS Store.

The ATS International Conference will wrap up its final Year in Review session on Wednesday morning, with experts sharing highlights from research papers in their field. Deepshikha Ashana, MD, MBA, MS, will discuss health equity. Race correction in spirometry and global medical oxygen security are two hot topics in pulmonary medicine right now.

Josalyn Cho, MD, and Garth Garrison, MD, will co-chair the Pulmonary Core Curriculum, focusing on the diagnosis and management of asthma in various populations, as well as the impact the environment has on asthma. The two-part series will be presented in back-to-back Wednesday sessions.

Experts will discuss the importance of recognizing early symptoms of two rare conditions—interstitial lung disease and pulmonary hypertension in infants—in the third session of this series led by Pediatric Core Curriculum Chair Jane Gross, MD, PhD.

A panel of experts, including Charles Corey Hardin, MD, PhD, ATSF, will discuss techniques for phenotyping patients with common critical care syndromes to help researchers assemble clinical trial cohorts likely to experience similar treatment effects due to similar biology.